
Heart ‘Rewiring’ Shows Rapid Effect on Dangerous Arrhythmia
A new analysis of two clinical trials reveals that a procedure called epicardial ablation dramatically reduces the risk of life-threatening heart rhythms in people with malignant Brugada syndrome. This targeted therapy, which addresses faulty electrical tissue on the heart's surface, shows a measurable benefit within weeks, offering a significant improvement over existing treatments alone.
By Barbosa, Oliveira, Consoli, Pisani, Darrieux, Brugada, Scanavacca

